Abstract
Background: The etonogestrel subdermal implant (ESI) is the most effective method of contraception and is recommended for adolescents. Although bothersome irregular and frequent bleeding is a common reason for early ESI discontinuation, 22-30% of patients become amenorrheic by 1 year of use. There are data on baseline predictors of abnormal uterine bleeding among adolescent and adult ESI users, but no studies have assessed predictors of amenorrhea. Our objective was to determine what baseline clinical characteristics are associated with amenorrhea in adolescents with an ESI.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
